Report overview
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Cancer Vaccines. This report contains market size and forecasts of Dendritic Cell Cancer Vaccines in global, including the following market information:
Global Dendritic Cell Cancer Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dendritic Cell Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
We surveyed the Dendritic Cell Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dendritic Cell Cancer Vaccines, market overview.
Chapter 2: Global Dendritic Cell Cancer Vaccines market size in revenue.
Chapter 3: Detailed analysis of Dendritic Cell Cancer Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dendritic Cell Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
